THE EFFECTS OF ASHWAGANDHA (WITHANIA SOMNIFERA) ON INSOMNIA AND SLEEP QUALITY - A NARRATIVE REVIEW
DOI:
https://doi.org/10.31435/ijitss.3(51).2026.6350Keywords:
Ashwagandha, Insomia, Sleep Quality, Sleep DisturbancesAbstract
Insomnia is one of the most common sleep disorders in modern society and represents a major public health concern due to its wide-ranging impact on physical health, mental well-being, and overall quality of life. Due to the escalating prevalence of sleep disorders and the potential side effects associated with conventional pharmacotherapy, there is a growing clinical and public interest in natural substances that can safely support the treatment of insomnia.
The purpose of this review was to evaluate the current state of knowledge regarding the clinical and preclinical efficacy of Ashwagandha (Withania somnifera) in treating insomnia and sleep disturbances, while elucidating its underlying neurobiological mechanisms of action. A structured narrative literature review was conducted by searching major biomedical databases.
The analyzed studies demonstrated that ashwagandha supplementation leads to statistically significant improvements in sleep metrics. In patients diagnosed with insomnia, researchers reported a shortened sleep onset latency (SOL), reduced waking after sleep onset (WASO), and increased total sleep time (TST). The majority of findings consistently underscore that Ashwagandha’s most profound impact on sleep architecture is driven by its interactions with the GABAergic pathway. Furthermore, supplementation correlated with a significant reduction in serum cortisol levels by a multi-pathway mechanism of action involving the hypothalamic-pituitary-adrenal (HPA) axis. The extracts were well-tolerated, with only mild and transient adverse effects reported.
Ashwagandha represents an effective and safe therapeutic alternative for managing insomnia and enhancing sleep quality, particularly in individuals experiencing chronic stress.
References
Roth, T. (2007). Insomnia: Definition, prevalence, etiology, and consequences. Journal of Clinical Sleep Medicine, 3(5 Suppl), S7–S10.
Sateia, M. J., Buysse, D. J., Krystal, A. D., Neubauer, D. N., & Heald, J. L. (2017). Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults. Journal of Clinical Sleep Medicine, 13(2), 307–349. https://doi.org/10.5664/jcsm.6470
Shechter, A., Quispe, K. A., Mizhquiri Barbecho, J. S., Slater, C., & Falzon, L. (2020). Interventions to reduce short-wavelength (“blue”) light exposure at night and their effects on sleep: A systematic review and meta-analysis. Sleep Advances, 1(1), zpaa002. https://doi.org/10.1093/sleepadvances/zpaa002
Benz, F., Meneo, D., Baglioni, C., & Hertenstein, E. (2023). Insomnia symptoms as risk factor for somatic disorders: An umbrella review of systematic reviews and meta-analyses. Journal of Sleep Research, 32(6), e13984. https://doi.org/10.1111/jsr.13984
Katz, D. A., & McHorney, C. A. (1998). Clinical correlates of insomnia in patients with chronic illness. Archives of Internal Medicine, 158(10), 1099–1107. https://doi.org/10.1001/archinte.158.10.1099
Aquino, G., Benz, F., Dressle, R. J., Gemignani, A., Alfì, G., Palagini, L., Spiegelhalder, K., Riemann, D., & Feige, B. (2024). Towards the neurobiology of insomnia: A systematic review of neuroimaging studies. Sleep Medicine Reviews, 73, 101878.
Stepanski, E., Zorick, F., Roehrs, T., Young, D., & Roth, T. (1988). Daytime alertness in patients with chronic insomnia compared with asymptomatic control subjects. Sleep, 11(1), 54–60. https://doi.org/10.1093/sleep/11.1.54
Alvaro, P. K., Roberts, R. M., & Harris, J. K. (2013). A systematic review assessing bidirectionality between sleep disturbances, anxiety, and depression. Sleep, 36(7), 1059–1068. https://doi.org/10.5665/sleep.2810
Schwartz, M. D., & Kilduff, T. S. (2015). The neurobiology of sleep and wakefulness. Psychiatric Clinics of North America, 38(4), 615–644. https://doi.org/10.1016/j.psc.2015.07.002
Ashwagandha. (2024). In LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.ncbi.nlm.nih.gov/books/
John, J. (2014). Therapeutic potential of Withania somnifera: A report on phyto-pharmacological properties. International Journal of Pharmaceutical Sciences and Research, 5, 2131–2148.
Wiciński, M., Fajkiel-Madajczyk, A., Kurant, Z., Kurant, D., Gryczka, K., Falkowski, M., Wiśniewska, M., Słupski, M., Ohla, J., & Zabrzyński, J. (2023). Can Ashwagandha benefit the endocrine system? A review. International Journal of Molecular Sciences, 24(22), 16513. https://doi.org/10.3390/ijms242216513
Candelario, M., Cuellar, E., Reyes-Ruiz, J. M., Darabedian, N., Feimeng, Z., Miledi, R., Russo-Neustadt, A., & Limon, A. (2015). Direct evidence for GABAergic activity of Withania somnifera. Journal of Ethnopharmacology, 171, 264–272. https://doi.org/10.1016/j.jep.2015.05.058
Mikulska, P., Malinowska, M., Ignacyk, M., et al. (2023). Ashwagandha (Withania somnifera)—Current research on health-promoting activities. Pharmaceutics, 15(4), 1057. https://doi.org/10.3390/pharmaceutics15041057
Langade, D., Thakare, V., Kanchi, S., & Kelgane, S. (2021). Clinical evaluation of Ashwagandha extract on sleep. Journal of Ethnopharmacology, 264, 113276. https://doi.org/10.1016/j.jep.2020.113276
Deshpande, A., Irani, N., Balkrishnan, R., & Benny, I. R. (2020). Ashwagandha extract improves sleep quality. Sleep Medicine, 72, 28–36. https://doi.org/10.1016/j.sleep.2020.03.012
Langade, D., Kanchi, S., Salve, J., Debnath, K., & Ambegaokar, D. (2019). Efficacy of Ashwagandha in insomnia and anxiety. Cureus, 11(9), e5797. https://doi.org/10.7759/cureus.5797
Kaushik, M. K., Kaul, S. C., Wadhwa, R., Yanagisawa, M., & Urade, Y. (2017). Triethylene glycol induces sleep. PLoS ONE, 12(2), e0172508. https://doi.org/10.1371/journal.pone.0172508
Murthy, S. V., Fathima, S. N., & Mote, R. (2022). Ashwagandha improves sleep via GABA and histamine modulation. Preventive Nutrition and Food Science, 27(1), 108–120. https://doi.org/10.3746/pnf.2022.27.1.108
Bhattarai, J. P., Park, S. A., & Han, S. K. (2010). Withania somnifera acts on GABA receptors. Phytotherapy Research, 24(8), 1147–1150. https://doi.org/10.1002/ptr.3088
Cheah, K. L., Norhayati, M. N., & Rahman, R. A. (2021). Effect of Ashwagandha on sleep: Systematic review and meta-analysis. PLoS ONE, 16(9), e0257843. https://doi.org/10.1371/journal.pone.0257843
Park, C. W., Hong, K. B., Suh, H. J., & Ahn, Y. (2023). Sleep-promoting activity of Ashwagandha via GABA receptors. Journal of Food and Drug Analysis, 31(2), 278–288. https://doi.org/10.38212/2224-6614.3456
Er, B., et al. (2025). Ashwagandha mitigates sleep deprivation-induced impairment. Biomolecules, 15(5), 710. https://doi.org/10.3390/biom15050710
Mahadevan, M., et al. (2025). Zenroot™ improves sleep quality. Advances in Therapy, 42(10), 5238–5254. https://doi.org/10.1007/s12325-025-03327-z
Kelgane, S. B., Salve, J., Sampara, P., & Debnath, K. (2020). Ashwagandha in elderly patients. Cureus, 12(2), e7083. https://doi.org/10.7759/cureus.7083
Berry, R. B. (2023). EEG normal sleep. In StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK537023/
Kim, K., Uchiyama, M., Okawa, M., Liu, X., & Ogihara, R. (2012). Nonrestorative sleep. Sleep Medicine, 13(7), 786–794. https://doi.org/10.1016/j.sleep.2012.04.002
Staner, L. (2003). Sleep and anxiety disorders. Dialogues in Clinical Neuroscience, 5(3), 249–258. https://doi.org/10.31887/DCNS.2003.5.3/lstaner
Chandrasekhar, K., Kapoor, J., & Anishetty, S. (2012). Ashwagandha reduces stress and anxiety. Indian Journal of Psychological Medicine, 34(3), 255–262. https://doi.org/10.4103/0253-7176.106022
Nguyen, V., George, T., & Brewster, G. S. (2019). Insomnia in older adults. Current Geriatrics Reports, 8(4), 271–290. https://doi.org/10.1007/s13670-019-00300-x
Lee, Y., Kim, S., Park, J., et al. (2026). Ashwagandha modulates GABA and adenosine A1 receptors. Food Bioscience, 62, 105748. https://doi.org/10.1016/j.fbio.2026.105748
Bjorness, T. E., & Greene, R. W. (2009). Adenosine and sleep. Current Neuropharmacology, 7(3), 238–245. https://doi.org/10.2174/157015909789152182
de Pontes, A. L. B., et al. (2010). Serotonin and circadian rhythms. Psychology & Neuroscience, 3(2), 217–228. https://doi.org/10.3922/j.psns.2010.2.011
Sutanto, C. N., Loh, W. W., & Kim, J. E. (2022). The impact of tryptophan supplementation on sleep quality: A systematic review, meta-analysis, and meta-regression. Nutrition Reviews, 80(2), 306–316. https://doi.org/10.1093/nutrit/nuab027
Pérez-Piñero, S., Muñoz-Carrillo, J. C., Echepare-Taberna, J., et al. (2024). Effectiveness of enriched milk with Ashwagandha extract and tryptophan for improving subjective sleep quality in adults with sleep problems: A randomized double-blind controlled trial. Clocks & sleep, 6(3), 417–432. https://doi.org/10.3390/clockssleep6030028
Movva, N., Salve, J., Wankhede, K., et al. (2026). Comparative Evaluation of Ashwagandha (Withania somnifera) Root Extract and Melatonin for Improving Sleep Quality in Adults: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study. Clocks & sleep, 8(2), 15. https://doi.org/10.3390/clockssleep8020015
Savage, R. A., Zafar, N., Yohannan, S., & Miller, J. M. M. (2024). Melatonin. In StatPearls. StatPearls Publishing.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Alicja Maria Wielogórska, Aleksander Kamecki, Zuzanna Rak, Zuzanna Ignatowska, Karolina Dzień, Filip Sarek, Karol Jóźwik, Stanisław Kucharczyk
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
